BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 30857967)

  • 41. Persistent (recurrent) Spitz nevi: a histopathologic, immunohistochemical, and molecular pathologic study of 22 cases.
    Harvell JD; Bastian BC; LeBoit PE
    Am J Surg Pathol; 2002 May; 26(5):654-61. PubMed ID: 11979096
    [TBL] [Abstract][Full Text] [Related]  

  • 42. ROS1 pattern of immunostaining in 11 cases of spitzoid tumour: comparison with histopathological, fluorescence in-situ hybridisation and next-generation sequencing analysis.
    Cesinaro AM; Gallo G; Manfredini S; Maiorana A; Bettelli SR
    Histopathology; 2021 Dec; 79(6):966-974. PubMed ID: 34231248
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Expanding the Molecular Characterization of Thoracic Inflammatory Myofibroblastic Tumors beyond ALK Gene Rearrangements.
    Chang JC; Zhang L; Drilon AE; Chi P; Alaggio R; Borsu L; Benayed R; Travis WD; Ladanyi M; Antonescu CR
    J Thorac Oncol; 2019 May; 14(5):825-834. PubMed ID: 30550870
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The landscape of fusion transcripts in spitzoid melanoma and biologically indeterminate spitzoid tumors by RNA sequencing.
    Wu G; Barnhill RL; Lee S; Li Y; Shao Y; Easton J; Dalton J; Zhang J; Pappo A; Bahrami A
    Mod Pathol; 2016 Apr; 29(4):359-69. PubMed ID: 26892443
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Spitzoid melanoma with histopathological features of ALK gene rearrangement exhibiting ALK copy number gain: a novel mechanism of ALK activation in spitzoid neoplasia.
    Farah M; Nagarajan P; Curry JL; Tang Z; Kim TB; Aung PP; Torres-Cabala CA; Eterovic AK; Wargo JA; Prieto VG; Tetzlaff MT
    Br J Dermatol; 2019 Feb; 180(2):404-408. PubMed ID: 29897634
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Melanoma in infants, caused by a gene fusion involving the anaplastic lymphoma kinase (ALK).
    Perkins IU; Tan SY; McCalmont TH; Chou PM; Mully TW; Gerami P; Pomerantz JH; Reyes-Múgica M; Balkin DM; Kruse LL; Huang B; Reichek JL; Gangopadhyay N; Chiosea S; Green JR; Chamlin SL; Frieden IJ; Bastian BC; Yeh I
    Pigment Cell Melanoma Res; 2024 Jan; 37(1):6-14. PubMed ID: 37475109
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An Update on Molecular Genetic Aberrations in Spitz Melanocytic Proliferations: Correlation with Morphological Features and Biological Behavior.
    Šekoranja D; Pižem J; Luzar B
    Acta Med Acad; 2021 Apr; 50(1):157-174. PubMed ID: 34075771
    [TBL] [Abstract][Full Text] [Related]  

  • 48. p16 expression: a marker of differentiation between childhood malignant melanomas and Spitz nevi.
    Al Dhaybi R; Agoumi M; Gagné I; McCuaig C; Powell J; Kokta V
    J Am Acad Dermatol; 2011 Aug; 65(2):357-363. PubMed ID: 21550132
    [TBL] [Abstract][Full Text] [Related]  

  • 49. ALK-positive atypical Spitz tumour with conspicuous rosette-like structures.
    Minowa T; Hida T; Horimoto K; Kato J; Kamiya T; Sugita S; Idogawa M; Saida T; Hasegawa T; Tokino T; Uhara H
    Eur J Dermatol; 2021 Apr; 31(2):256-258. PubMed ID: 34001476
    [No Abstract]   [Full Text] [Related]  

  • 50. Spitzoid tumors in children and adults: a comparative clinical, pathological, and cytogenetic analysis.
    Dika E; Fanti PA; Fiorentino M; Capizzi E; Neri I; Piraccini BM; Ravaioli GM; Misciali C; Passarini B; Patrizi A
    Melanoma Res; 2015 Aug; 25(4):295-301. PubMed ID: 25933206
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Two cases of multiple spitz nevi: correlating clinical, histologic, and fluorescence in situ hybridization findings.
    Boone SL; Busam KJ; Marghoob AA; Fang Y; Guitart J; Martini M; Gerami P
    Arch Dermatol; 2011 Feb; 147(2):227-31. PubMed ID: 21339450
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pathologic Characteristics of Spitz Melanoma With MAP3K8 Fusion or Truncation in a Pediatric Cohort.
    Newman S; Pappo A; Raimondi S; Zhang J; Barnhill R; Bahrami A
    Am J Surg Pathol; 2019 Dec; 43(12):1631-1637. PubMed ID: 31498175
    [TBL] [Abstract][Full Text] [Related]  

  • 53. BRAF fusion Spitz neoplasms; clinical morphological, and genomic findings in six cases.
    Kim D; Khan AU; Compres EV; Zhang B; Sunshine JC; Quan VL; Gerami P
    J Cutan Pathol; 2020 Dec; 47(12):1132-1142. PubMed ID: 32776349
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Analysis of mutations in B-RAF, N-RAS, and H-RAS genes in the differential diagnosis of Spitz nevus and spitzoid melanoma.
    van Dijk MC; Bernsen MR; Ruiter DJ
    Am J Surg Pathol; 2005 Sep; 29(9):1145-51. PubMed ID: 16096402
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of Crizotinib Treatment in a Patient With Unresectable GOPC-ROS1 Fusion Agminated Spitz Nevi.
    Robertson SJ; Orme L; Teixeira R; Shamassi M; Newell F; Patch AM; Yeh I; Gard G; Wilmott J; Jackett L; LeBoit P; Fellowes A; MacArthur G; Fox S; Hayward NK; Bastian B; Scolyer R; Waddell N; Penington A; Shackleton M
    JAMA Dermatol; 2021 Jul; 157(7):836-841. PubMed ID: 34076666
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Polyploidy in spitz nevi: a not uncommon karyotypic abnormality identifiable by fluorescence in situ hybridization.
    Isaac AK; Lertsburapa T; Pathria Mundi J; Martini M; Guitart J; Gerami P
    Am J Dermatopathol; 2010 Apr; 32(2):144-8. PubMed ID: 20051813
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Differentiation between Spitz nevi and malignant melanomas by interphase fluorescence in situ hybridization.
    Wettengel GV; Draeger J; Kiesewetter F; Schell H; Neubauer S; Gebhart E
    Int J Oncol; 1999 Jun; 14(6):1177-83. PubMed ID: 10339676
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Absence of BRAF gene mutations differentiates spitz nevi from malignant melanoma.
    Mihic-Probst D; Perren A; Schmid S; Saremaslani P; Komminoth P; Heitz PU
    Anticancer Res; 2004; 24(4):2415-8. PubMed ID: 15330192
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Correlating array comparative genomic hybridization findings with histology and outcome in spitzoid melanocytic neoplasms.
    Ali L; Helm T; Cheney R; Conroy J; Sait S; Guitart J; Gerami P
    Int J Clin Exp Pathol; 2010 Jun; 3(6):593-9. PubMed ID: 20661407
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Targeted next generation sequencing (NGS) to classify melanocytic neoplasms.
    Zarabi SK; Azzato EM; Tu ZJ; Ni Y; Billings SD; Arbesman J; Funchain P; Gastman B; Farkas DH; Ko JS
    J Cutan Pathol; 2020 Aug; 47(8):691-704. PubMed ID: 32291779
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.